Wren Laboratories

Wren Laboratories has developed the NETest—a clinically validated blood-based assay that uses mRNA signatures analyzed by artificial intelligence to diagnose neuroendocrine tumors with high accuracy. The company’s broader portfolio includes precision molecular diagnostic solutions for multiple solid tumors. Their tests are used both clinically (for patient care) and by biopharma partners for translational research or companion diagnostic development. They are recognized leaders in applying machine learning to real-time molecular biomarker data from non-invasive samples like blood or saliva. Their laboratory holds CAP accreditation and CLIA certification across several US states.